From the Guidelines
Beta blockers do help lower diastolic blood pressure, with an expected reduction of approximately 5 mmHg with office BP and 3 mmHg with ABPM as monotherapy. According to the 2024 ESC guidelines for the management of elevated blood pressure and hypertension 1, the magnitude of BP reduction achieved with beta-blockers is similar to other main classes of BP-lowering medications.
Key Points to Consider
- Beta blockers work by blocking the effects of adrenaline on beta receptors in the heart and blood vessels, reducing heart rate, cardiac output, and the force of heart contractions.
- Common beta blockers include metoprolol, atenolol, propranolol, and bisoprolol.
- These medications are particularly effective for patients with high blood pressure accompanied by conditions like angina, heart failure, or previous heart attacks.
- Beta blockers may not be suitable first-line treatments for all patients, particularly older adults or those with certain conditions like asthma, COPD, or diabetes, as stated in the 2024 ESC guidelines 1.
- The guidelines also recommend combining beta-blockers with other major BP-lowering drug classes when there are compelling indications for their use, such as angina, post-myocardial infarction, heart failure with reduced ejection fraction, or for heart rate control 1.
Important Considerations for Treatment
- The BP-lowering effect of beta-blockers generally increases with the dose administered, though this relationship is not linear.
- Effects of each medication can vary at the individual level, sometimes requiring personalization by matching the patient with the best medication for them.
- The magnitude of BP reduction for any BP-lowering medication may increase as a function of the pre-treatment BP, which is also known as Wilders principle, as mentioned in the 2024 ESC guidelines 1.
From the FDA Drug Label
In standard animal or human pharmacological tests, beta-adrenoreceptor blocking activity of atenolol has been demonstrated by: (1) reduction in resting and exercise heart rate and cardiac output, (2) reduction of systolic and diastolic blood pressure at rest and on exercise Atenolol has been studied in combination with thiazide type diuretics, and the blood pressure effects of the combination are approximately additive. In controlled clinical trials, atenolol, given as a single daily oral dose, was an effective antihypertensive agent providing 24-hour reduction of blood pressure
Beta blockers help lower diastolic blood pressure. The antihypertensive effect of atenolol is evident in reducing both systolic and diastolic blood pressure at rest and on exercise 2.
From the Research
Beta Blockers and Diastolic Blood Pressure
- Beta blockers are a class of drugs commonly used to treat hypertension, and their effect on diastolic blood pressure has been studied in various trials 3, 4, 5, 6.
- A study published in 2010 found that beta blockers reduced diastolic blood pressure by 4-6 mmHg when used as a second-line therapy for primary hypertension 3.
- Another study published in 2014 found that nonselective beta blockers lowered diastolic blood pressure by 7 mmHg compared to placebo in people with primary hypertension 4.
- A 2016 study found that beta-1 selective blockers lowered diastolic blood pressure by 8 mmHg on average, with a greater reduction at peak hours (-9 mmHg) compared to trough hours (-7 mmHg) 5.
- Dual alpha and beta blockers were also found to lower diastolic blood pressure, with carvedilol reducing it by 3-4 mmHg and labetalol by 7 mmHg 6.
Comparison with Other Classes of Drugs
- Beta blockers have been compared to other classes of drugs, such as thiazide diuretics, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers, in terms of their effect on diastolic blood pressure 3, 5, 6.
- Beta-1 selective blockers were found to lower diastolic blood pressure by a greater degree than diuretics, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers 5.
- Dual alpha and beta blockers had a smaller effect on diastolic blood pressure compared to non-selective, beta1 selective, and partial agonist beta blockers, as well as thiazides and drugs inhibiting the renin angiotensin system 6.
Combination Therapy
- The combination of beta blockers and angiotensin-converting enzyme inhibitors has been found to provide effective blood pressure lowering and improved cardiovascular outcomes 7.
- This combination is of special interest due to the complementary actions of beta blockers and ACE inhibitors on the sympathetic nervous system and renin-angiotensin-aldosterone system, two interlinked pathways that influence cardiovascular risk and disease outcomes 7.